Dr.med. ID: 48118

Johann Felden

graph of relations

Publications

  1. 2019
  2. Detection of a Broad Range of Low-Level Major Histocompatibility Complex Class II-Restricted, Hepatitis Delta Virus (HDV)-Specific T-Cell Responses Regardless of Clinical Status

    Landahl, J., Bockmann, J. H., Scheurich, C., Ackermann, C., Matzat, V., Heide, J., Nuurei, T., D'Antonio, G., von Felden, J., Sette, A., Peine, S., Lohse, A. W., Lütgehetmann, M., Marget, M., Sidney, J. & Schulze Zur Wiesch, J., 29.01.2019, In: J INFECT DIS. 219, 4, p. 568-577 10 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  3. The Impact of Translational Research in Hepatology

    von Felden, J., Craig, A. J. & Villanueva, A., 01.2019, In: Clin Liver Dis (Hoboken). 13, 1, p. 29-33 5 p.

    Research output: SCORING: Contribution to journalSCORING: Review articleResearch

  4. 2018
  5. Genetic variants in PNPLA3 and TM6SF2 predispose to the development of hepatocellular carcinoma in individuals with alcohol-related cirrhosis

    Stickel, F., Buch, S., Nischalke, H. D., Weiss, K. H., Gotthardt, D., Fischer, J., Rosendahl, J., Marot, A., Elamly, M., Casper, M., Lammert, F., McQuillin, A., Zopf, S., Spengler, U., Marhenke, S., Kirstein, M. M., Vogel, A., Eyer, F., von Felden, J., Wege, H., Buch, T., Schafmayer, C., Braun, F., Deltenre, P., Berg, T., Morgan, M. Y. & Hampe, J., 10.2018, In: AM J GASTROENTEROL. 113, 10, p. 1475-1483 9 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  6. High-density single cell mRNA sequencing to characterize circulating tumor cells in hepatocellular carcinoma

    D'Avola, D., Villacorta-Martin, C., Martins-Filho, S. N., Craig, A., Labgaa, I., von Felden, J., Kimaada, A., Bonaccorso, A., Tabrizian, P., Hartmann, B. M., Sebra, R., Schwartz, M. & Villanueva, A., 01.08.2018, In: SCI REP-UK. 8, p. 11570

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  7. A pilot study of ultra-deep targeted sequencing of plasma DNA identifies driver mutations in hepatocellular carcinoma

    Labgaa, I., Villacorta-Martin, C., D'Avola, D., Craig, A. J., von Felden, J., Martins-Filho, S. N., Sia, D., Stueck, A., Ward, S. C., Fiel, M. I., Mahajan, M., Tabrizian, P., Thung, S. N., Ang, C., Friedman, S. L., Llovet, J. M., Schwartz, M. & Villanueva, A., 07.2018, In: ONCOGENE. 37, 27, p. 3740-3752 13 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  8. Correction: Genetic Variants in PNPLA3 and TM6SF2 Predispose to the Development of Hepatocellular Carcinoma in Individuals With Alcohol-Related Cirrhosis

    Stickel, F., Buch, S., Nischalke, H. D., Weiss, K. H., Gotthardt, D., Fischer, J., Rosendahl, J., Marot, A., Elamly, M., Casper, M., Lammert, F., McQuillin, A., Zopf, S., Spengler, U., Marhenke, S., Kirstein, M. M., Vogel, A., Eyer, F., von Felden, J., Wege, H., Buch, T., Schafmayer, C., Braun, F., Deltenre, P., Berg, T., Morgan, M. Y. & Hampe, J., 07.2018, In: AM J GASTROENTEROL. 113, 7, p. 1099

    Research output: SCORING: Contribution to journalOther (editorial matter etc.)Research

  9. Role of circulating tumor DNA to help decision-making in hepatocellular carcinoma

    von Felden, J., Craig, A. J. & Villanueva, A., 07.2018, In: Oncoscience. 5, 7-8, p. 209-211 3 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  10. Editorial: genotype 3 HCV-who still needs ribavirin in a pan-genotypic era? Authors' reply.

    von Felden, J., Vermehren, J., Schulze Zur Wiesch, J., Sarrazin, C. & Christensen, S., 06.2018, In: ALIMENT PHARM THER. 47, 11, p. 1550-1551 2 p.

    Research output: SCORING: Contribution to journalOther (editorial matter etc.)Research

  11. High efficacy of sofosbuvir/velpatasvir and impact of baseline resistance-associated substitutions in hepatitis C genotype 3 infection

    von Felden, J., Vermehren, J., Ingiliz, P., Mauss, S., Lutz, T., Simon, K. G., Busch, H. W., Baumgarten, A., Schewe, K., Hueppe, D., Boesecke, C., Rockstroh, J. K., Daeumer, M., Luebke, N., Timm, J., Schulze Zur Wiesch, J., Sarrazin, C. & Christensen, S., 05.2018, In: ALIMENT PHARM THER. 47, 9, p. 1288-1295 8 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  12. Usefulness of biochemical remission and transient elastography in monitoring disease course in autoimmune hepatitis

    Hartl, J., Ehlken, H., Sebode, M., Peiseler, M., Krech, T., Zenouzi, R., von Felden, J., Weiler-Normann, C., Schramm, C. & Lohse, A. W., 04.2018, In: J HEPATOL. 68, 4, p. 754-763 10 p., 4.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  13. Levels of Cytokines in Serum Associate With Development of Hepatocellular Carcinoma in Patients With HCV Infection Treated With Direct-Acting Antivirals

    Debes, J. D., van Tilborg, M., Groothuismink, Z. M. A., Hansen, B. E., Schulze Zur Wiesch, J., von Felden, J., de Knegt, R. J. & Boonstra, A., 02.2018, In: GASTROENTEROLOGY. 154, 3, p. 515-517

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  14. Successful treatment of chronic hepatitis C with ground ledipasvir/sofosbuvir in a patient with Crohn's disease and short bowel syndrome

    von Felden, J., Scheurich, C., Yamamura, J., Brainard, D. M., Mogalian, E., Lohse, A. W. & Schulze Zur Wiesch, J., 02.2018, In: J VIRAL HEPATITIS. 25, 2, p. 214-215 2 p.

    Research output: SCORING: Contribution to journalOther (editorial matter etc.)Research

  15. 2017
  16. Circulating tumor cells as liquid biomarker for high HCC recurrence risk after curative liver resection

    von Felden, J., Schulze, K., Krech, T., Ewald, F., Nashan, B., Pantel, K., Lohse, A. W., Riethdorf, S. & Wege, H., 27.10.2017, In: ONCOTARGET. 8, 52, p. 89978-89987 10 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  17. Molecular profiling of liver cancer heterogeneity

    Craig, A. J., von Felden, J. & Villanueva, A., 09.2017, In: DISCOV MED. 24, 131, p. 117-125 9 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  18. High expression of micro RNA-135A in hepatocellular carcinoma is associated with recurrence within 12 months after resection

    von Felden, J., Heim, D., Schulze, K., Krech, T., Ewald, F., Nashan, B., Lohse, A. W. & Wege, H., 18.01.2017, In: BMC CANCER. 17, 1, p. 60

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  19. 2016
  20. First- and Second-Line Targeted Systemic Therapy in Hepatocellular Carcinoma-An Update on Patient Selection and Response Evaluation

    von Felden, J., Schulze, K., Gil-Ibanez, I., Werner, T. & Wege, H., 28.11.2016, In: DIAGNOSTICS. 6, 4, p. E44

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  21. 2015
  22. MAP-Kinase Activated Protein Kinase 2 Links Endothelial Activation and Monocyte/macrophage Recruitment in Arteriogenesis

    Limbourg, A., von Felden, J., Jagavelu, K., Krishnasamy, K., Napp, L. C., Kapopara, P. R., Gaestel, M., Schieffer, B., Bauersachs, J., Limbourg, F. P. & Bavendiek, U., 2015, In: PLOS ONE. 10, 10, p. e0138542

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  23. 2014
  24. Deficiency of MAPK-activated protein kinase 2 (MK2) prevents adverse remodelling and promotes endothelial healing after arterial injury

    Kapopara, P. R., von Felden, J., Soehnlein, O., Wang, Y., Napp, L. C., Sonnenschein, K., Wollert, K. C., Schieffer, B., Gaestel, M., Bauersachs, J. & Bavendiek, U., 12.2014, In: THROMB HAEMOSTASIS. 112, 6, p. 1264-76 13 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  25. Mitogen-activated protein kinase-activated protein kinase 2 deficiency reduces insulin sensitivity in high-fat diet-fed mice

    de Boer, J. F., Dikkers, A., Jurdzinski, A., von Felden, J., Gaestel, M., Bavendiek, U. & Tietge, U. J. F., 2014, In: PLOS ONE. 9, 9, p. e106300

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  26. 2013
  27. Drug-induced acute liver injury mimicking autoimmune hepatitis after intake of dietary supplements containing glucosamine and chondroitin sulfate

    von Felden, J., Montani, M., Kessebohm, K. & Stickel, F., 03.2013, In: INT J CLIN PHARM TH. 51, 3, p. 219-23 5 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  28. 2012
  29. Transsignaling of interleukin-6 crucially contributes to atherosclerosis in mice

    Schuett, H., Oestreich, R., Waetzig, G. H., Annema, W., Luchtefeld, M., Hillmer, A., Bavendiek, U., von Felden, J., Divchev, D., Kempf, T., Wollert, K. C., Seegert, D., Rose-John, S., Tietge, U. J. F., Schieffer, B. & Grote, K., 02.2012, In: ARTERIOSCL THROM VAS. 32, 2, p. 281-90 10 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

Previous 1 2 Next